Lv5
990 积分 2024-07-29 加入
Tertiary lymphoid structures in hepatocellular carcinoma: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy
27分钟前
待确认
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
29分钟前
待确认
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
3个月前
已完结
Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence
3个月前
已完结
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
3个月前
已完结
Genomic and the tumor microenvironment heterogeneity in multifocal hepatocellular carcinoma
4个月前
已完结
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab
4个月前
已完结
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
4个月前
已完结
Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis
4个月前
已完结
Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
5个月前
已完结
皖公网安备34019202002308
